Updated-Pfizer faces disappointment with anticancers after more Phase II failures
13 September 2010
Asher Mullard
Please Login to read the full article.
13 September 2010
Asher Mullard
Please Login to read the full article.
RELATED CONTENT
NEWS
- Bayer/J&J report positive Xarelto results in Japanese AF patients
- Bayer posts fourth quarter loss alongside strong sales in 2010
- BMS and Sanofi mentioned in $1bn deal speculation over Biocon's oral insulin
- Gilead's Truvada cut risk of HIV infection by up to 78% in heterosexuals
